Bank of America has hired a trio of senior bankers to spearhead its healthcare dealmaking in Europe, according to sources familiar with the matter. The move underscores the bank's ambition to expand its footprint in the healthcare investment banking sector, which has seen a surge in activity amid the pandemic.
New Leadership in Healthcare Banking
The three bankers, who join from rival institutions, will be responsible for advising clients on mergers, acquisitions, and capital raising in the healthcare space across Europe. They bring extensive experience in pharmaceuticals, biotech, and medical devices.
Strategic Push in a Growing Sector
Healthcare has become a focal point for investment banks as deal volumes rise, driven by innovation and consolidation. Bank of America's hires are part of a broader trend of banks bolstering their healthcare teams to capture market share.
The new team members will report to the head of European healthcare investment banking and will collaborate with colleagues globally to serve clients. The appointments come as the bank aims to deepen relationships with healthcare companies and private equity firms active in the sector.
Industry experts note that healthcare M&A in Europe has been robust, with large pharma companies seeking to acquire innovative biotech firms and medical technology providers. Bank of America's enhanced team is well-positioned to advise on these complex transactions.
In addition to M&A, the bankers will focus on equity and debt financing for healthcare clients, leveraging the bank's capital markets expertise. The hires reflect a commitment to providing comprehensive advisory services in a rapidly evolving industry.
